chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: MENB
Symptoms: Vomiting
Clinical narrative: Approximately 8 minutes after patient received vaccine 248 PM she said that she just did not feel good that she was light headed and nauseas. States that when she got to lobby to finish waiting her 15 minutes she went to bathroom to vomit. When nurse got to her in bathroom she was pale, clammy but never loss conciseness. Patient stated that she has done that in past with giving blood but not immunizations. Patient was taken back to exam room and assisted to lie down and given water to drink and given a fan to cool down. BP was taken at 3:00 PM and it was within normal limits at  114/76. Patient  was allowed to cool off and drink water and she also got a piece of candy in case she was having a drop in her blood sugar. After another 15 minutes she stated she felt much better and more like herself and her BP was taken again at 3:15 PM and it was still stable 116/74. Patient  walked out of the clinic in stable condition with her grandmother at her side. No other reactions noted. Patient never had LOC.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Hypotension, Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD 12/9/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I95.9 HYPOTENSION 4/25/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA
Age: 29.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema
Clinical narrative: Patient received on 7/14/23. On 7/15/23, she noticed redness to her left upper arm. She went to the ED later in the day on 7/15/23. She was diagnosed with Left arm cellulitis. She was prescribed two different antibiotics, Keflex and Bactrim x 7 days. Patient still taking medications.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Product preparation error
Clinical narrative: He was due for Mcv4 and The M.A ended up only grabbing the juice only, not both vials. So he was vaccinated incorrectly.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Fall, Head injury, Loss of consciousness
Clinical narrative: Pt was seen to receive her second dose of Bexsero. Pt consented to immunization and reviewed before receiving her injection. She received her vaccine injection in the clinic's exam room and then made her way to the front desk to check out. At check out, the pt asked for water then lost consciousness and fell to the floor. She fell backwards and hit the base of her posterior skull on the vinyl flooring. RN was alerted and came to the patients side. The pt regained consciousness for a about 30 seconds and then loss consciousness again. RN applied cool towels and water bottles and talked to the pt until she regained consciousness 1 minute later. Within 2 minutes of her fall, pt was alert and asked for her mother. EMS was contacted. RN took VS HR 56 and BP 116/72. Pt slowly started to regain color in her face and cheeks. Pt drank water and ate granola bar while waiting for EMS.  EMS arrived within 8 minutes and took over care. VS and BG were checked by EMS staff.  Her injury to the back of her head was evaluated. No wound or bruising was observed. Pt was advised on what symptoms to watch for regarding concussion protocol and denied being taken to the ER. Pt's mother arrived and accompanied pt home.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Furuncle, Hypoaesthesia, Laboratory test abnormal, Laryngitis, Migraine
Clinical narrative: My throat closed, I went to urgent care and was diagnosed with laryngitis 2 days after receiving the vaccine and it didn't go away for two weeks. I developed huge pus filled boils under my arms and in my groin area after one week and I still have the after effects of them. I developed numbness in my extremedies with a tingling sensation and severe migraines after about two weeks and I still have that effect.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pustule, Throat tightness
Clinical narrative: My throat closed, I went to urgent care and was diagnosed with laryngitis 2 days after receiving the vaccine and it didn't go away for two weeks. I developed huge pus filled boils under my arms and in my groin area after one week and I still have the after effects of them. I developed numbness in my extremedies with a tingling sensation and severe migraines after about two weeks and I still have that effect.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lacunar stroke
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Hypersensitivity, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS ACUTE PULMONARY EMBOLISM ALLERGIC REACTION, INIT 1/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, C-reactive protein increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen normal, Computerised tomogram head abnormal, Computerised tomogram thorax normal, Confusional state, Cough
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine positive, Decreased appetite, Dyspnoea exertional, Echocardiogram normal, Ejection fraction
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Endodontic procedure, Hypokalaemia, Infection, Malnutrition, Mental status changes
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic encephalopathy, Procalcitonin increased, SARS-CoV-2 test positive, Sepsis, Staphylococcal bacteraemia
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcus test positive, Tooth abscess, Urinary tract infection, Urine analysis abnormal, White blood cell disorder
Clinical narrative: Patient is a 84 y.o. female patient of, MD with history of dementia, COPD, and mood disorder who presented to  Hospital with altered mental status, dyspnea on exertion and diagnosed with COVID-19 infection and MSSA bacteremia   Assessment and Plan   Sepsis due to unknown source, POA MSSA bacteremia Blood cultures 2 out of 2 grew MSSA No obvious source of infection, denies back or neck pain Son states patient had dental abscess with root canal done end of January 2023. CT maxillofacial without contrast-periapical lucencies sugestive of dental abscess, ? Right source CT Chest and abdominal  negative Echo with no vegetation and normal LVEF On Ancef 2 g IV every 8 hours day #2, repeat blood cultures on 4/24 NGTD Afebrile, WBC normalized Check WBC scan-results noted and discussed with son no further imaging planned as it does not alter the ongoing management. Discussed about need for clinical monitoring  after completion of IV antibiotics and son verbalized understanding. D/w ID and felt stable for discharge home on IV rocephin 2g daily for two weeks F/u discharge protocol for labs monitoring while on antibiotic and repeat blood culture one week after IV antibiotic as instructed     Acute respiratory failure with hypoxia- resolved COVID-19 virus infection with potential bacterial superinfection Date of onset of symptoms: Unable to determine from patient, but declining mental status over the last several days Symptoms present on admission: Confusion, chronic cough without change Date of covid positive test: 4/21/2023 Vaccination status: vaccinated Imaging: CXR showed no acute findings. CTPA chest and abdomen showed no PE, bibasilar atelectasis, possible trace pleural effusion Oxygen requirements on admission: 2 L Current oxygen requirements: O2 sats in low 90s on room air Medical therapy: not indicated Anticipated special isolation end date: 4/27/23 per ID Inflammatory markers; CRP 122 To maintain dry lung strategy we will give Lasix 20 mg x 1 Procalcitonin elevated secondary to MSSA Antibiotics changed to Ancef as mentioned above     Acute UTI Abnormal urine analysis with urine cultures positive for Staphylococcus Monitor PVR, straight cath as needed if bladder scan greater than 300 mL On Ancef as mentioned above   COPD Not in acute exacerbation As needed bronchodilators Resumed outpatient Advair (changed to Symbicort per formulary)   Dementia Continue home Aricept, Namenda, and Remeron   Acute metabolic encephalopathy Suspect secondary to infection in setting of baseline dementia Started on Seroquel 25 mg at bedtime, wean as able Continue to monitor with treatment of above issues Frequent orientations and avoid sedation Hypokalemia Received 1 dose of Lasix on 4/22 for dry lung strategy Check mag level Supplement oral potassium again and  recheck in a.m.   Moderate Malnutrition Poor appetite over the last several days Augment nutrition
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pneumonia aspiration
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 11/18/2022 ASPIRATION PNEUMONIA ACUTE DVT OF LEFT FEMORAL VEIN 11/18/2022 ASPIRATION PNEUMONIA
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Foreign body in gastrointestinal tract, Hypersensitivity
Clinical narrative: T78.40XA ALLERGIC REACTION, INIT 4/30/2023 FOREIGN BODY IN ESOPHAGUS, INIT T78.40XD ALLERGIC REACTION, SUBSEQ 5/3/2023 FOREIGN BODY IN ESOPHAGUS, INIT
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Sneezing, Tinnitus
Clinical narrative: Tinnitus- constant high pitched sound since last year. Sneezing - daily sneezing.  Seldom. Occurred before vaccination Warm hands-started few weeks after second dose.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sleep apnoea syndrome
Clinical narrative: SLEEP APNEA
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Hypersensitivity
Clinical narrative: T78.40XA ALLERGIC REACTION, INIT 3/2023 NORMAL DELIVERY
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 60 y.o. female patient of, MD with history of diabetes mellitus type 2 on insulin, hypertension, hyperlipidemia who presented to Hospital with hyperglycemia, hypoxia and fever.  Patient was transferred from ED   Acute respiratory failure with hypoxia COVID-19 infection Date of onset of symptoms: 5/1/23 Symptoms present on admission: fever, sore throat, dry cough Date of covid positive test: 5/2/23 Vaccination status: vaccinated Imaging: CXR no acute focal infiltrate Oxygen requirements on admission: 2L NC Current oxygen requirements: Currently weaned to room air Infectious disease following Continue Decadron, remdesivir Stable for discharge home   Hyperglycemia Diabetes mellitus type 2 on insulin A1c 10.4 up from 10, 5 months ago Labs on admission with normal bicarb and anion gap with glucose 332 States she is taking Lantus 17 units nightly, Farxiga 10 mg daily and metformin 2000 mg nightly. Lantus 25 units nightly plus SSI.  Adjust as needed   AKI - resolved At OLH creatinine was 1.86 ->1.13 >1.17 baseline 1.11.3 Avoid nephrotoxic agents   Hypertension Takes amlodipine 5 mg nightly at home and hydrochlorothiazide 25 mg daily Continue amlodipine.  Resume hydrochlorothiazide
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Hyperglycaemia, Hypertension, Hypoxia, Oropharyngeal pain
Clinical narrative: Patient is a 60 y.o. female patient of, MD with history of diabetes mellitus type 2 on insulin, hypertension, hyperlipidemia who presented to Hospital with hyperglycemia, hypoxia and fever.  Patient was transferred from ED   Acute respiratory failure with hypoxia COVID-19 infection Date of onset of symptoms: 5/1/23 Symptoms present on admission: fever, sore throat, dry cough Date of covid positive test: 5/2/23 Vaccination status: vaccinated Imaging: CXR no acute focal infiltrate Oxygen requirements on admission: 2L NC Current oxygen requirements: Currently weaned to room air Infectious disease following Continue Decadron, remdesivir Stable for discharge home   Hyperglycemia Diabetes mellitus type 2 on insulin A1c 10.4 up from 10, 5 months ago Labs on admission with normal bicarb and anion gap with glucose 332 States she is taking Lantus 17 units nightly, Farxiga 10 mg daily and metformin 2000 mg nightly. Lantus 25 units nightly plus SSI.  Adjust as needed   AKI - resolved At OLH creatinine was 1.86 ->1.13 >1.17 baseline 1.11.3 Avoid nephrotoxic agents   Hypertension Takes amlodipine 5 mg nightly at home and hydrochlorothiazide 25 mg daily Continue amlodipine.  Resume hydrochlorothiazide
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 60 y.o. female patient of, MD with history of diabetes mellitus type 2 on insulin, hypertension, hyperlipidemia who presented to Hospital with hyperglycemia, hypoxia and fever.  Patient was transferred from ED   Acute respiratory failure with hypoxia COVID-19 infection Date of onset of symptoms: 5/1/23 Symptoms present on admission: fever, sore throat, dry cough Date of covid positive test: 5/2/23 Vaccination status: vaccinated Imaging: CXR no acute focal infiltrate Oxygen requirements on admission: 2L NC Current oxygen requirements: Currently weaned to room air Infectious disease following Continue Decadron, remdesivir Stable for discharge home   Hyperglycemia Diabetes mellitus type 2 on insulin A1c 10.4 up from 10, 5 months ago Labs on admission with normal bicarb and anion gap with glucose 332 States she is taking Lantus 17 units nightly, Farxiga 10 mg daily and metformin 2000 mg nightly. Lantus 25 units nightly plus SSI.  Adjust as needed   AKI - resolved At OLH creatinine was 1.86 ->1.13 >1.17 baseline 1.11.3 Avoid nephrotoxic agents   Hypertension Takes amlodipine 5 mg nightly at home and hydrochlorothiazide 25 mg daily Continue amlodipine.  Resume hydrochlorothiazide
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Obstructive sleep apnoea syndrome, Pulmonary imaging procedure abnormal
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 2/24/2023 ABNL LUNG IMAGING CHRONIC RESPIRATORY FAILURE 1/12/2023 ABNL LUNG IMAGING
Age: 0.17
Sex: M
Vaccine: UNK, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Immunoglobulin therapy, Platelet count decreased, Thrombocytopenia
Clinical narrative: Low plts requiring IVIG.
Age: 0.17
Sex: M
Vaccine: UNK, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Haemoglobin, Petechiae, Platelet count decreased
Clinical narrative: Low plts requiring IVIG.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Completed suicide, Condition aggravated, Depression, Pain
Clinical narrative: Intractable body pain and burning, seizure, worsening of depression. multiple suicide attempts SUICIDE
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure, Suicide attempt
Clinical narrative: Intractable body pain and burning, seizure, worsening of depression. multiple suicide attempts SUICIDE
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Aortic aneurysm, Aortic stenosis, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 84 y.o. male past medical history of severe aortic stenosis, COPD who presented from home on 5/3/2023 with 1 day of fever, altered mental status and subsequently tested positive for COVID-19.  Patient noted to have delta positive troponins and hypoxia   Acute Hypoxic Respiratory Failure -Due to COVID-19 infection with suspected viral pneumonia -No evidence of PE on CTPA -Clinically does not appear volume overloaded on admission.  Viral pneumonia COVID-19 Infection - Presented with: lethargy, fever - Symptom onset: 5/3 - Positive COVID-19: 5/4/23 at facility - Vaccination status: yes - CXR on admission showed bibasilar infiltrates - Oxygen status: 2L NC  - PO Decadron for 10 days total - Seen by Pulmonology   - Treated with Remdesivir x3 days hererecommended by Pulm   Elevated troponin -Possibly demand ischemia from hypoxia, and infection.  No chest pain, syncope, dyspnea noted.   -Troponin 52-- >92  - CTPA show pneumonia - Seen by Cardiology (Dr) - TTE show EF45-50%, mod/severe AR, pulm htn - Recommend close outpatient f/u with Cardiology (follows with Dr)   Acute Metabolic Encephalopathy - Mild, waxing/waning - Likely multifactorial due to covid infection, hospital delerium - Nonfocal neuro exam - CT head non-acute - Resolved   COPD -Per history.  No wheezing appreciated during my exam though noted by EMS and while in the emergency department. -PFTs 4/2023: Moderate to severe obstructive disease, normal DLCO -Patient has been initiated on steroids for COVID-pneumonia as above which would also provide management for COPD -Continue home bronchodilator regimen -Follows with pulmonary, Dr.    Severe Aortic Stenosis Bicuspid AV Thoracic Aortic Aneurysm -Does not appear volume overloaded on admission -TTE 5/22: EF 56%, severe AS with AVA 0.7, mean gradient 39, mild to moderate MR, RVSP 59 -BNP 10,500 -TTE ordered -Resume home beta-blocker -Patient undergoing work-up for possible TAVR and is due for repeat echo. Follows with cardio, Dr    HTN -Continue home Lopressor, ACE inhibitor -No leukocytosis -CXR: Mild bilateral lower lung infiltrates vs. Edema, trace bilateral pleural effusions -CTPA with premedication for contrast allergy ordered -Decadron for COVID infection -Hypoxic on room air, currently with adequate oxygenation on 2 L nasal cannula   V
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray abnormal, Chronic obstructive pulmonary disease, Computerised tomogram thorax, Delirium, Echocardiogram
Clinical narrative: Patient is a 84 y.o. male past medical history of severe aortic stenosis, COPD who presented from home on 5/3/2023 with 1 day of fever, altered mental status and subsequently tested positive for COVID-19.  Patient noted to have delta positive troponins and hypoxia   Acute Hypoxic Respiratory Failure -Due to COVID-19 infection with suspected viral pneumonia -No evidence of PE on CTPA -Clinically does not appear volume overloaded on admission.  Viral pneumonia COVID-19 Infection - Presented with: lethargy, fever - Symptom onset: 5/3 - Positive COVID-19: 5/4/23 at facility - Vaccination status: yes - CXR on admission showed bibasilar infiltrates - Oxygen status: 2L NC  - PO Decadron for 10 days total - Seen by Pulmonology   - Treated with Remdesivir x3 days hererecommended by Pulm   Elevated troponin -Possibly demand ischemia from hypoxia, and infection.  No chest pain, syncope, dyspnea noted.   -Troponin 52-- >92  - CTPA show pneumonia - Seen by Cardiology (Dr) - TTE show EF45-50%, mod/severe AR, pulm htn - Recommend close outpatient f/u with Cardiology (follows with Dr)   Acute Metabolic Encephalopathy - Mild, waxing/waning - Likely multifactorial due to covid infection, hospital delerium - Nonfocal neuro exam - CT head non-acute - Resolved   COPD -Per history.  No wheezing appreciated during my exam though noted by EMS and while in the emergency department. -PFTs 4/2023: Moderate to severe obstructive disease, normal DLCO -Patient has been initiated on steroids for COVID-pneumonia as above which would also provide management for COPD -Continue home bronchodilator regimen -Follows with pulmonary, Dr.    Severe Aortic Stenosis Bicuspid AV Thoracic Aortic Aneurysm -Does not appear volume overloaded on admission -TTE 5/22: EF 56%, severe AS with AVA 0.7, mean gradient 39, mild to moderate MR, RVSP 59 -BNP 10,500 -TTE ordered -Resume home beta-blocker -Patient undergoing work-up for possible TAVR and is due for repeat echo. Follows with cardio, Dr    HTN -Continue home Lopressor, ACE inhibitor -No leukocytosis -CXR: Mild bilateral lower lung infiltrates vs. Edema, trace bilateral pleural effusions -CTPA with premedication for contrast allergy ordered -Decadron for COVID infection -Hypoxic on room air, currently with adequate oxygenation on 2 L nasal cannula   V
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ejection fraction decreased, Hypertension, Hypoxia, Lethargy, Lung infiltration
Clinical narrative: Patient is a 84 y.o. male past medical history of severe aortic stenosis, COPD who presented from home on 5/3/2023 with 1 day of fever, altered mental status and subsequently tested positive for COVID-19.  Patient noted to have delta positive troponins and hypoxia   Acute Hypoxic Respiratory Failure -Due to COVID-19 infection with suspected viral pneumonia -No evidence of PE on CTPA -Clinically does not appear volume overloaded on admission.  Viral pneumonia COVID-19 Infection - Presented with: lethargy, fever - Symptom onset: 5/3 - Positive COVID-19: 5/4/23 at facility - Vaccination status: yes - CXR on admission showed bibasilar infiltrates - Oxygen status: 2L NC  - PO Decadron for 10 days total - Seen by Pulmonology   - Treated with Remdesivir x3 days hererecommended by Pulm   Elevated troponin -Possibly demand ischemia from hypoxia, and infection.  No chest pain, syncope, dyspnea noted.   -Troponin 52-- >92  - CTPA show pneumonia - Seen by Cardiology (Dr) - TTE show EF45-50%, mod/severe AR, pulm htn - Recommend close outpatient f/u with Cardiology (follows with Dr)   Acute Metabolic Encephalopathy - Mild, waxing/waning - Likely multifactorial due to covid infection, hospital delerium - Nonfocal neuro exam - CT head non-acute - Resolved   COPD -Per history.  No wheezing appreciated during my exam though noted by EMS and while in the emergency department. -PFTs 4/2023: Moderate to severe obstructive disease, normal DLCO -Patient has been initiated on steroids for COVID-pneumonia as above which would also provide management for COPD -Continue home bronchodilator regimen -Follows with pulmonary, Dr.    Severe Aortic Stenosis Bicuspid AV Thoracic Aortic Aneurysm -Does not appear volume overloaded on admission -TTE 5/22: EF 56%, severe AS with AVA 0.7, mean gradient 39, mild to moderate MR, RVSP 59 -BNP 10,500 -TTE ordered -Resume home beta-blocker -Patient undergoing work-up for possible TAVR and is due for repeat echo. Follows with cardio, Dr    HTN -Continue home Lopressor, ACE inhibitor -No leukocytosis -CXR: Mild bilateral lower lung infiltrates vs. Edema, trace bilateral pleural effusions -CTPA with premedication for contrast allergy ordered -Decadron for COVID infection -Hypoxic on room air, currently with adequate oxygenation on 2 L nasal cannula   V
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Mental status changes, Metabolic encephalopathy, Mitral valve incompetence, Pleural effusion, Pneumonia viral
Clinical narrative: Patient is a 84 y.o. male past medical history of severe aortic stenosis, COPD who presented from home on 5/3/2023 with 1 day of fever, altered mental status and subsequently tested positive for COVID-19.  Patient noted to have delta positive troponins and hypoxia   Acute Hypoxic Respiratory Failure -Due to COVID-19 infection with suspected viral pneumonia -No evidence of PE on CTPA -Clinically does not appear volume overloaded on admission.  Viral pneumonia COVID-19 Infection - Presented with: lethargy, fever - Symptom onset: 5/3 - Positive COVID-19: 5/4/23 at facility - Vaccination status: yes - CXR on admission showed bibasilar infiltrates - Oxygen status: 2L NC  - PO Decadron for 10 days total - Seen by Pulmonology   - Treated with Remdesivir x3 days hererecommended by Pulm   Elevated troponin -Possibly demand ischemia from hypoxia, and infection.  No chest pain, syncope, dyspnea noted.   -Troponin 52-- >92  - CTPA show pneumonia - Seen by Cardiology (Dr) - TTE show EF45-50%, mod/severe AR, pulm htn - Recommend close outpatient f/u with Cardiology (follows with Dr)   Acute Metabolic Encephalopathy - Mild, waxing/waning - Likely multifactorial due to covid infection, hospital delerium - Nonfocal neuro exam - CT head non-acute - Resolved   COPD -Per history.  No wheezing appreciated during my exam though noted by EMS and while in the emergency department. -PFTs 4/2023: Moderate to severe obstructive disease, normal DLCO -Patient has been initiated on steroids for COVID-pneumonia as above which would also provide management for COPD -Continue home bronchodilator regimen -Follows with pulmonary, Dr.    Severe Aortic Stenosis Bicuspid AV Thoracic Aortic Aneurysm -Does not appear volume overloaded on admission -TTE 5/22: EF 56%, severe AS with AVA 0.7, mean gradient 39, mild to moderate MR, RVSP 59 -BNP 10,500 -TTE ordered -Resume home beta-blocker -Patient undergoing work-up for possible TAVR and is due for repeat echo. Follows with cardio, Dr    HTN -Continue home Lopressor, ACE inhibitor -No leukocytosis -CXR: Mild bilateral lower lung infiltrates vs. Edema, trace bilateral pleural effusions -CTPA with premedication for contrast allergy ordered -Decadron for COVID infection -Hypoxic on room air, currently with adequate oxygenation on 2 L nasal cannula   V
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pulmonary hypertension, Pulmonary oedema, Pyrexia, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient is a 84 y.o. male past medical history of severe aortic stenosis, COPD who presented from home on 5/3/2023 with 1 day of fever, altered mental status and subsequently tested positive for COVID-19.  Patient noted to have delta positive troponins and hypoxia   Acute Hypoxic Respiratory Failure -Due to COVID-19 infection with suspected viral pneumonia -No evidence of PE on CTPA -Clinically does not appear volume overloaded on admission.  Viral pneumonia COVID-19 Infection - Presented with: lethargy, fever - Symptom onset: 5/3 - Positive COVID-19: 5/4/23 at facility - Vaccination status: yes - CXR on admission showed bibasilar infiltrates - Oxygen status: 2L NC  - PO Decadron for 10 days total - Seen by Pulmonology   - Treated with Remdesivir x3 days hererecommended by Pulm   Elevated troponin -Possibly demand ischemia from hypoxia, and infection.  No chest pain, syncope, dyspnea noted.   -Troponin 52-- >92  - CTPA show pneumonia - Seen by Cardiology (Dr) - TTE show EF45-50%, mod/severe AR, pulm htn - Recommend close outpatient f/u with Cardiology (follows with Dr)   Acute Metabolic Encephalopathy - Mild, waxing/waning - Likely multifactorial due to covid infection, hospital delerium - Nonfocal neuro exam - CT head non-acute - Resolved   COPD -Per history.  No wheezing appreciated during my exam though noted by EMS and while in the emergency department. -PFTs 4/2023: Moderate to severe obstructive disease, normal DLCO -Patient has been initiated on steroids for COVID-pneumonia as above which would also provide management for COPD -Continue home bronchodilator regimen -Follows with pulmonary, Dr.    Severe Aortic Stenosis Bicuspid AV Thoracic Aortic Aneurysm -Does not appear volume overloaded on admission -TTE 5/22: EF 56%, severe AS with AVA 0.7, mean gradient 39, mild to moderate MR, RVSP 59 -BNP 10,500 -TTE ordered -Resume home beta-blocker -Patient undergoing work-up for possible TAVR and is due for repeat echo. Follows with cardio, Dr    HTN -Continue home Lopressor, ACE inhibitor -No leukocytosis -CXR: Mild bilateral lower lung infiltrates vs. Edema, trace bilateral pleural effusions -CTPA with premedication for contrast allergy ordered -Decadron for COVID infection -Hypoxic on room air, currently with adequate oxygenation on 2 L nasal cannula   V
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Hypoxia, Neuropathy peripheral, Respiratory failure
Clinical narrative: NEUROPATHY CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Myocardial ischaemia, Polyneuropathy
Clinical narrative: POLYNEUROPATHY DEMAND ISCHEMIA
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Irritability, Pyrexia
Clinical narrative: fever x 2 days, fatigue, irritability; fever resolved now
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure, Symptom recurrence
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/9/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Pain, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/15/2023 CHRONIC PAIN SYNDROME
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 2/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Hypotension
Clinical narrative: HYPOTENSION 4/8/2023 ASTHMA, UNSPECIFIED
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bell's palsy, Facial paresis
Clinical narrative: LEFT BELLS PALSY LEFT FACIAL MUSCLE WEAKNESS
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Embolic stroke
Clinical narrative: ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: throat swelling
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood test, Chest X-ray, Chest pain, Chills, Computerised tomogram abdomen
Clinical narrative: Fever, chills, muscle ache on July 13. On July 17th, chest pain, shortness of breath, pulmonary embolism, bilateral.
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Computerised tomogram thorax, Dyspnoea, Myalgia, Pulmonary embolism, Pyrexia
Clinical narrative: Fever, chills, muscle ache on July 13. On July 17th, chest pain, shortness of breath, pulmonary embolism, bilateral.
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Scan with contrast
Clinical narrative: Fever, chills, muscle ache on July 13. On July 17th, chest pain, shortness of breath, pulmonary embolism, bilateral.
Age: 0.58
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Underdose, Wrong product administered
Clinical narrative: 5/1/23: Patient received their first COVID vaccine, but received the 0.2 mL/10 ug from dark pink cap/yellow label boarder instead of the 0.25 mL/25 ug from blue cap/gray label border. 6/14/23: Patient received their first COVID vaccine, but received the 0.2 mL/10 ug from dark pink cap/yellow label boarder instead of the 0.25 mL/25 ug from blue cap/gray label border. On 7/3/23 we noticed "Inadvertent Vaccine - Inadvertent Administration" in his database so we reached out to agency to find out what that meant and were told he received the wrong vaccine. Patient's mother was notified by email and phone call.
Age: 84.0
Sex: M
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Symptom recurrence
Clinical narrative: ACUTE DVT OF LEFT FEMORAL VEIN 2/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Severe fever 104+, then chills and shaking.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Covid-related death
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT
Age: 1.25
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Vaccine was administered to patient without dilutant..
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Deep vein thrombosis, Hypotension, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN HYPOTENSION ACUTE RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM 1/24/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Product was not diluted prior to administration. Pt received 0.2 ml of undiluted Pfizer bivalent 5-11 year old vaccine ( "orange top")
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Pain, Rash
Clinical narrative: Clinet reported that about an hour after receiving the vaccine she had chills and body aches and after about 5 hours she noticed a rash to upper thighs.
Age: 89.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Covid-related death
Age: 2.0
Sex: F
Vaccine: DTPPVHBHPB, PNC13, DTPPVHBHPB, PNC13
Symptoms: Asthenia, Dysstasia, Fatigue, Gait inability
Clinical narrative: Patient received Vaxelis and PCV yesterday morning. A few hours later she was showing signs of increased fatigue but still wanted to go outside. When Mom took her outside she couldn't stay standing due to weakness. Mom gave her Tylenol twice yesterday. Mom said she wouldn't walk or stand yesterday and it is the same today. Today Mom gave her some Motrin but that did not help with symptoms and continues to not be able to stand or walk.     Recommendation: Triaged per protocol. After more discussion about severity of symptoms with the inability to walk or stand advised Mom to take her to the Emergency Department.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Ophthalmic herpes zoster
Clinical narrative: Shingle like symptom around left eye area 3 days after shot.
Age: 19.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given on 7/14/23 however, vaccine was OUT OF USE date as of 7/10/23.  No adverse effect reported.  Vaccine pulled from stock and patient to be notified once connect with company for further direction.  This was her 3rd vaccine after receiving Dose #1 and #2 in 2021.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure fluctuation, Blood test normal, Computerised tomogram normal, Headache, Magnetic resonance imaging normal
Clinical narrative: Headache. Mild headache post vaccine for 2 days. Then post vaccine about 6-7 days severe headache lasting for over 30 days. Headaches now come and go multiple times per day but never quite go away.  Historically I have very rarely had headaches. My first Covid Vaccines were Pfizer and no reaction whatsoever. The Vaccine on June 15, 2023 was Moderna. OTC meds like aspirin, ibuprofen or tylenol do not help. No other symptoms.